NCT02044523
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +20 more
- Locations
-
- Centre Hospitalier de l'Université de Montréal Montreal, Quebec, Canada
Clinical trial condition
Hepatitis B
Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.
458 public trials
28 recruiting studies
Hepatitis B trial results
Completed
Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B Vaccine
NCT00524576
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Westmead, New South Wales, Australia
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Wilrijk, Belgium
Completed
Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult
NCT01000324
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Wilrijk, Belgium
NCT00875485
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Hradec Králové, Czechia
NCT00289744
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site Wilrijk, Belgium
NCT01248884
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
- Locations
-
- GSK Investigational Site Santo Domingo, Dominican Republic
- GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
- GSK Investigational Site Espoo, Finland
- GSK Investigational Site Helsinki, Finland
NCT01090453
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
- Locations
-
- GSK Investigational Site Vancouver, British Columbia, Canada
- GSK Investigational Site Winnipeg, Manitoba, Canada
- GSK Investigational Site Hamilton, Ontario, Canada
- GSK Investigational Site Aix-en-Provence, France
NCT00805389
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Ghent, Belgium
- GSK Investigational Site La Louvière, Belgium
- GSK Investigational Site Wilrijk, Belgium
NCT00984139
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
- Locations
-
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Pforzheim, Baden-Wurttemberg, Germany
NCT00197184
- Conditions
- Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +12 more
- Locations
-
- GSK Investigational Site North Adelaide, South Australia, Australia
- GSK Investigational Site Carlton, Victoria, Australia
- GSK Investigational Site Brussels, Belgium
- GSK Investigational Site Barcelona, Spain